HealthEquity, Inc. is projected to rise to $122.89 by 2027, a +22% move from its current price of $100.99. HQY is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $99.16 | $101.03 | $102.94 | +0.04% |
| Aug 2 | $98.44 | $101.07 | $103.78 | +0.08% |
| Aug 3 | $97.89 | $101.11 | $104.44 | +0.12% |
| Aug 4 | $97.44 | $101.15 | $105.00 | +0.16% |
| Aug 5 | $97.05 | $101.19 | $105.51 | +0.20% |
| Aug 6 | $96.71 | $101.23 | $105.98 | +0.24% |
| Aug 7 | $96.39 | $101.28 | $106.41 | +0.28% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $96.39 | $101.28 | $106.41 | +0.28% |
| Week 2 | $94.70 | $101.56 | $108.92 | +0.57% |
| Week 3 | $93.49 | $101.85 | $110.95 | +0.85% |
| Week 4 | $92.52 | $102.14 | $112.75 | +1.14% |
| Week 5 | $91.71 | $102.43 | $114.40 | +1.42% |
| Week 6 | $91.00 | $102.72 | $115.94 | +1.71% |
| Week 7 | $90.38 | $103.01 | $117.40 | +2.00% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States.
It offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a Web-based tool. The company also provides flexible spending accounts (FSA) for health and dependent care; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. In addition, the company offers HSA and FSA members with access to certain healthcare products, programs, and services through its marketplace.
It serves clients through a direct sales force; and brokers and advisors, a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers.
HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.
HQY is categorized in Healthcare. The current price is $98.88, with a market cap of $8.29B and a rank of 967.
The forecast projects upside from here, with 2026 avg $98.88, 2030 avg $217.33, 2040 avg $584.43, and 2050 avg $1,354.85, suggesting meaningful upside over the long horizon.
A major floor 25.3% below — a decisive break under it would weaken the trend.
The nearest floor, 17.4% below — buyers have tended to step in here.
The nearest ceiling, 3.1% above — a clean break opens room to run.
A major ceiling 15.7% above — clearing it would confirm fresh momentum.
Key HQY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HQY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $100.01 | Buy | $100.47 | Buy |
| MA 10 | $98.46 | Buy | $98.91 | Buy |
| MA 20 | $97.07 | Buy | $96.65 | Buy |
| MA 50 | $91.29 | Buy | $92.28 | Buy |
| MA 100 | $86.59 | Buy | $89.43 | Buy |
| MA 200 | $88.50 | Buy | $88.97 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.91 | Neutral |
| Stoch RSI (14) | 50.25 | Neutral |
| CCI (20) | 119.53 | Buy |
| Williams %R (14) | -32.04 | Info |
| MACD (12,26,9) | 0.33 | Buy |
| ROC (12) | 6.87 | Buy |
| Bollinger %B (20,2) | 0.87 | Neutral |
| Stochastic %K (14) | 67.96 | Neutral |
| TRIX (15) | 0.41 | Buy |
| Awesome (5,34) | 7.08 | Buy |
| Ultimate (7,14,28) | 61.62 | Neutral |
| Momentum (10) | 2.30 | Buy |
| Aroon Osc (25) | 92.00 | Buy |
| Hull MA (9) | 103.17 | Sell |
| ADX (14) | 23.27 | Buy |
| ATR (14) | 1.82 | Info |
The 30-day technical picture is bullish, with RSI(14) at 70. SMA50 is $88.74 and SMA200 is $88.17. Support is at $83.43 and resistance is at $98.88. The 30-day range runs from $88.60 to $110.35.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $73.21 | $100.99 | $135.92 | 0% | Neutral | |
| $100.76 | $122.89 | $156.61 | +22% | Bullish | |
| $118.67 | $147.49 | $193.13 | +46% | Bullish | |
| $155.11 | $195.77 | $261.87 | +94% | Bullish | |
| $172.22 | $220.33 | $300.07 | +118% | Bullish | |
| $191.25 | $247.67 | $342.67 | +145% | Bullish | |
| $208.08 | $272.53 | $382.46 | +170% | Bullish | |
| $213.77 | $282.93 | $402.22 | +180% | Bullish | |
| $252.73 | $337.84 | $486.04 | +235% | Bullish | |
| $294.69 | $397.67 | $578.51 | +294% | Bullish | |
| $417.78 | $588.06 | $896.61 | +482% | Bullish | |
| $919.26 | $1,387.82 | $2,268.49 | +12.7x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $73.21 | $100.99 | $117.70 | +0.00% |
| August 2026 | $89.62 | $104.49 | $124.17 | +3.47% |
| September 2026 | $89.35 | $104.78 | $125.68 | +0.27% |
| October 2026 | $89.85 | $105.85 | $127.91 | +1.03% |
| November 2026 | $92.81 | $109.75 | $133.42 | +3.68% |
| December 2026 | $93.71 | $111.20 | $135.92 | +1.32% |
Click any year to see its month-by-month HQY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The HQY price prediction for 2026 points to an average of $100.99 (low $73.21, high $135.92) — a potential gain of 0% on today's $100.99. A consolidation phase looks the most probable path here.
In 2027, HQY is projected to trade between $100.76 and $156.61, averaging $122.89 — a potential gain of +22% from today's $100.99. That is up +22% on the projected 2026 average. Momentum favours further upside here.
HealthEquity, Inc.'s 2028 outlook centres on $147.49, within a $118.67 to $193.13 range. That is up +20% on the projected 2027 average. That marks a +46% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, HQY could reach as high as $261.87, with a base case around $195.77 and support toward $155.11 — roughly +94% from $100.99. Momentum favours further upside here.
Expect HQY to range from $172.22 to $300.07 through 2030. The $220.33 average target implies a +118% move from current prices. That is up +13% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The HQY price prediction for 2031 points to an average of $247.67 (low $191.25, high $342.67) — a potential gain of +145% on today's $100.99. Momentum favours further upside here.
In 2032, HQY is projected to trade between $208.08 and $382.46, averaging $272.53 — a potential gain of +170% from today's $100.99. That is up +10% on the projected 2031 average. Buyers look set to stay in control over this stretch.
HealthEquity, Inc.'s 2033 outlook centres on $282.93, within a $213.77 to $402.22 range. That is up +4% on the projected 2032 average. That marks a +180% change versus current levels. Momentum favours further upside here.
By 2034, HQY could reach as high as $486.04, with a base case around $337.84 and support toward $252.73 — roughly +235% from $100.99. Buyers look set to stay in control over this stretch.
Expect HQY to range from $294.69 to $578.51 through 2035. The $397.67 average target implies a +294% move from current prices. That is up +18% on the projected 2034 average. Momentum favours further upside here.
The HQY price prediction for 2040 points to an average of $588.06 (low $417.78, high $896.61) — a potential gain of +482% on today's $100.99. Buyers look set to stay in control over this stretch.
In 2050, HQY is projected to trade between $919.26 and $2,268.49, averaging $1,387.82 — a potential gain of +12.7x from today's $100.99. That is up +136% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in HQY today (≈ 9.90197 HQY) could be worth
$13,742.16
+$12,742.16 (+1274%) by 2050 · US Dollar
Based on the average projected HQY price of $1,387.82 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HQYwould be worth at today's price.
$1,000 invested in HQY on Jul 30, 2025 (≈ 10.121457 HQY) would be worth
$1,022.17
+$22.17 (+2.2%) today · 1.02× · US Dollar
Based on a HQY entry price of $98.8 vs. today's $100.99.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $94.33 | $1,070.6 | +7.1% |
| 1 month ago | $90.32 | $1,118.14 | +11.8% |
| 3 months ago | $82.4 | $1,225.61 | +22.6% |
| 6 months ago | $85.67 | $1,178.83 | +17.9% |
| 1 year ago | $98.8 | $1,022.17 | +2.2% |
| All time (5.0y) ago | $74.17 | $1,361.6 | +36.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HQY forecast.
Our base-case forecast reaches $200.00 around 2030.
Implied market cap at $200.00: $16.77B
The multi-year forecast shows a bullish trajectory with substantial upside. In 2027 the avg price is $120.88 (ROI 22.3), 2028 is $146.44 (ROI 48.1), 2029 is $192.28 (ROI 94.5), and 2030 is $217.33 (ROI 119.8).
Further out, 2040 shows an avg of $584.43 (ROI 491.1) and 2050 shows an avg of $1,354.85 (ROI 1270.2).
These are estimates, not guarantees, and reflect inherent uncertainty in long-horizon projections and market conditions.
Tap a question to reveal the answer.
2030 forecast shows an avg price of $217.33, with a min of $169.82 and a max of $296.11. The ROI is 119.8 and the sentiment is BULLISH.
Forecasts indicate bullish sentiment from 2027 onward with rising avg prices and ROIs. Key points: 2027 avg $120.88 (ROI 22.3), 2028 avg $146.44 (ROI 48.1), 2029 avg $192.28 (ROI 94.5), 2030 avg $217.33 (ROI 119.8), 2040 avg $584.43 (ROI 491.1), 2050 avg $1,354.85 (ROI 1270.2). These are estimates, not guarantees.
Yes. The forecast max in 2027 is $154.19, with 2028 max $191.88 and 2029 max $257.33, so reaching $150 is within the forecast by 2027.
2040 forecast shows an avg price of $584.43, with a min of $415.11 and a max of $891.28. The ROI is 491.1 and sentiment is BULLISH.
Current price is $98.88 and market cap is $8.29B.
HealthEquity, Inc. Community Discussion
0Share your HealthEquity, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.